{
    "2020-05-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "FDA approves Eli Lilly drug for thyroid, lung cancers driven by a genetic mutation",
                "features": {
                    "keywords": [
                        "FDA",
                        "Eli Lilly",
                        "drug",
                        "thyroid",
                        "lung cancers",
                        "genetic mutation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "NIAID to Test Gilead's Remdesivir together with Lilly's Olumiant for Coronavirus",
                "features": {
                    "keywords": [
                        "NIAID",
                        "Gilead",
                        "Remdesivir",
                        "Lilly",
                        "Olumiant",
                        "Coronavirus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Government to test remdesivir with Lilly drug in COVID-19 patients",
                "features": {
                    "keywords": [
                        "Government",
                        "remdesivir",
                        "Lilly",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19",
                "features": {
                    "keywords": [
                        "NIH",
                        "remdesivir",
                        "anti-inflammatory",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Higher investigational doses of TrulicityÂ® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes",
                "features": {
                    "keywords": [
                        "Trulicity",
                        "dulaglutide",
                        "A1C",
                        "body weight",
                        "type 2 diabetes"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Biopharmas Where BofA Would Put Its Money To Work",
                "features": {
                    "keywords": [
                        "Biopharmas",
                        "BofA",
                        "investment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "Q1 Earnings",
                        "BMY",
                        "NVO",
                        "PFE",
                        "RHHBY"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates",
                "features": {
                    "keywords": [
                        "OPKO Health",
                        "Q1 Loss",
                        "Revenue Estimates"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Globus Medical (GMED) Misses on Q1 Earnings and Revenues",
                "features": {
                    "keywords": [
                        "Globus Medical",
                        "Q1 Earnings",
                        "Revenues"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Omnicell (OMCL) Q1 Earnings Top, Operating Margin Rises",
                "features": {
                    "keywords": [
                        "Omnicell",
                        "Q1 Earnings",
                        "Operating Margin"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top",
                "features": {
                    "keywords": [
                        "Avanos Medical",
                        "Q1 Earnings",
                        "Estimates",
                        "Revenues"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "DENTSPLY SIRONA (XRAY) Posts Weak Q1 Preliminary Results",
                "features": {
                    "keywords": [
                        "DENTSPLY SIRONA",
                        "Q1 Preliminary Results"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "dental products"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Integra (IART) Lags Q1 Earnings Estimates, Withdraws Outlook",
                "features": {
                    "keywords": [
                        "Integra",
                        "Q1 Earnings",
                        "Outlook"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "Glaukos",
                        "Q1 Earnings",
                        "Revenues"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "ophthalmology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Bruker (BRKR) Q1 Earnings Miss Estimates, Guidance Suspended",
                "features": {
                    "keywords": [
                        "Bruker",
                        "Q1 Earnings",
                        "Guidance"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "scientific instruments"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline",
                "features": {
                    "keywords": [
                        "Stock Charts",
                        "Bristol-Myers Squibb",
                        "Eli Lilly",
                        "GlaxoSmithKline"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pacific Biosciences (PACB) Q1 Earnings Surpass Estimates",
                "features": {
                    "keywords": [
                        "Pacific Biosciences",
                        "Q1 Earnings",
                        "Estimates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}